-
GHWP Chair and WHO representatives held online meeting
2024-12-20
GHWP Chair Dr.Xu Jinghe and Mr. Hiiti B. Sillo, the Unit Head, Regulation and Safety within the WHO Department of Regulation and Prequalification as well as other WHO representatives held an online meeting on May 7th.
-
Speech at the First GHWP (Guangzhou) Academy Training
2024-12-20
Speech at the First GHWP (Guangzhou) Academy Training
-
Innovative Medical Devices Embrace the World: The 1st Training of GHWP (Guangzhou) Academy Successfully kicked-off
2024-12-20
In the morning of May 27th, the GHWP (Global Harmonization Working Party) (Guangzhou) Academy held its inaugural training session at South China University of Technology in Guangzhou. T
-
Dr. Xu Jinghe Attended the 2nd GHWP (Guangzhou) Academy Training
2024-12-20
On November 24, the 2nd Global Harmonization Working Party (GHWP) (Guangzhou) Academy training was held in Shenzhen.
-
4 innovative products including implantable deep brain stimulation electrode lead kit approved for marketing
2024-05-28
Recently, the China NMPA approved the registration applications for 4 innovative products developed by Beijing PINS Medical Co., Ltd., including implantable deep brain stimulation electrode lead kit, dual channel rechargeable implantable deep brain stimulation pulse generator kit, dual channel implantable deep brain stimulation pulse generator kit and implantable deep brain stimulation extension lead kit.
-
NMPA Announcement on Further Strengthening the Supervision and Administration of Entrusted Manufacturing by Registrants of Medical Devices (No.38, 2024)
2024-04-03
Pursuant to the implementation of the Regulations for the Supervision and Administration of Medical Devices, and with the objective of fully enforcing the primary responsibility for quality and safety on the part of the registrant of medical devices (hereinafter referred to as “Registrant”), this announcement aims to further strengthen the supervision and administration of entrusted manufacturing by registrants of medical devices, and enable effective prevention and control of quality and safety risks associated with medical devices.
